Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from OSR Holdings ( (OSRH) ).
On October 13, 2025, OSR Holdings Co., Ltd. (OSRK), a subsidiary of OSR Holdings Inc., entered into an agreement to acquire Woori IO Co., Ltd. (WORIO), a South Korean medical-device company specializing in non-invasive glucose monitoring technology. This acquisition, valued at approximately KRW 15 billion (USD 10.6 million), will make WORIO a wholly owned subsidiary of OSRK, with the transaction expected to close on January 12, 2026. WORIO’s innovative near-infrared spectroscopy platform for needle-free glucose monitoring aligns with OSRH’s strategy to enhance its medical-device platform and capture a share of the global glucose-monitoring market, projected to be worth over $40 billion by 2030. The acquisition is expected to strengthen OSRH’s industry positioning by integrating WORIO’s technology and leveraging its partnership with a major consumer electronics company for clinical development.
More about OSR Holdings
OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company focused on advancing biomedical innovation in health and wellness. Through its subsidiaries, the company engages in immuno-oncology, regenerative biologics, and medical device technologies, aiming to build a portfolio of breakthrough healthcare solutions to improve global health outcomes.
Average Trading Volume: 5,192,898
Technical Sentiment Signal: Sell
Current Market Cap: $12.95M
For an in-depth examination of OSRH stock, go to TipRanks’ Overview page.